Practice
Featured experience
Incora emerges from chapter 11
We advised an ad hoc group of secured noteholders in connection with Incora’s chapter 11 proceedings
Venture Global $1.75 billion IPO
We advised Venture Global on its IPO and NYSE listing
Interactive Brokers claims for domestic production activities deductions
We are representing Interactive Brokers
Advice to multiple companies on potential tax refunds under the Varian ruling
We are representing clients in refund claims
Crestview strategic investment in The Gersh Agency
We advised Crestview Partners on the transaction
Constellation Brands $750 million senior notes offering
The investment-grade notes are due 2033
MedSci Healthcare Holdings HK$608 million IPO
We advised MedSci on its IPO and HKEX listing
ZJLD Group HK$5.3 billion IPO
We advised ZJLD on its IPO and HKEX listing
PGE $300 million at-the-market offering
The common stock is listed on the NYSE
IDEAYA Biosciences $201 million equity offering
The common stock is listed on the Nasdaq Global Select Market
Canada $4 billion global bond offering
The investment-grade bonds are due 2028
Morgan Stanley $6 billion senior notes offering
We advised Morgan Stanley on its SEC-registered global offering
Bank of America $8.5 billion fixed-to-floating-rate notes
The investment-grade notes are due 2029 and 2034
Pilgrim’s Pride $1 billion notes offering
The investment-grade notes are due 2033